Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 354

1.

Potent in vitro activity of β-D-4'-chloromethyl-2'-deoxy-2'-fluorocytidine against Nipah virus.

Lo MK, Amblard F, Flint M, Chatterjee P, Kasthuri M, Li C, Russell O, Verma K, Bassit L, Schinazi RF, Nichol ST, Spiropoulou CF.

Antiviral Res. 2020 Jan 11:104712. doi: 10.1016/j.antiviral.2020.104712. [Epub ahead of print]

PMID:
31935422
2.

Corrigendum to: In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster Model.

Welch SR, Scholte FEM, Harmon JR, Coleman-Mccray JD, Lo MK, Montgomery JM, Nichol ST, Spiropoulou CF, Spengler JR.

J Infect Dis. 2019 Dec 31. pii: jiz627. doi: 10.1093/infdis/jiz627. [Epub ahead of print] No abstract available.

PMID:
31891167
3.

Isolation and phylogenomic analysis of buffalopox virus from human and buffaloes in India.

Yadav PD, Mauldin MR, Nyayanit DA, Albariño CG, Sarkale P, Shete A, Guerrero LW, Nakazawa Y, Nichol ST, Mourya DT.

Virus Res. 2019 Dec 9;277:197836. doi: 10.1016/j.virusres.2019.197836. [Epub ahead of print]

PMID:
31821842
4.

Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in IFNAR-/- mice.

Welch SR, Ritter JM, McElroy AK, Harmon JR, Coleman-McCray JD, Scholte FEM, Kobinger GP, Bergeron É, Zaki SR, Nichol ST, Spengler JR, Spiropoulou CF.

PLoS Pathog. 2019 Dec 2;15(12):e1008183. doi: 10.1371/journal.ppat.1008183. [Epub ahead of print]

5.

Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.

Lo MK, Spengler JR, Welch SR, Harmon JR, Coleman-Mccray JD, Scholte FEM, Shrivastava-Ranjan P, Montgomery JM, Nichol ST, Weissman D, Spiropoulou CF.

J Infect Dis. 2019 Nov 21. pii: jiz553. doi: 10.1093/infdis/jiz553. [Epub ahead of print]

PMID:
31751453
6.

Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model.

Genzer SC, Welch SR, Scholte FEM, Harmon JR, Coleman-McCray JD, Lo MK, Montgomery JM, Nichol ST, Spiropoulou CF, Spengler JR.

J Infect Dis. 2019 Nov 20. pii: jiz552. doi: 10.1093/infdis/jiz552. [Epub ahead of print]

PMID:
31747016
7.

In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster Model.

Welch SR, Scholte FEM, Harmon JR, Coleman-McCray JD, Lo MK, Montgomery JM, Nichol ST, Spiropoulou CF, Spengler JR.

J Infect Dis. 2019 Oct 30. pii: jiz393. doi: 10.1093/infdis/jiz393. [Epub ahead of print]

PMID:
31665342
8.

Lassa virus circulating in Liberia: a retrospective genomic characterisation.

Wiley MR, Fakoli L, Letizia AG, Welch SR, Ladner JT, Prieto K, Reyes D, Espy N, Chitty JA, Pratt CB, Di Paola N, Taweh F, Williams D, Saindon J, Davis WG, Patel K, Holland M, Negrón D, Ströher U, Nichol ST, Sozhamannan S, Rollin PE, Dogba J, Nyenswah T, Bolay F, Albariño CG, Fallah M, Palacios G.

Lancet Infect Dis. 2019 Dec;19(12):1371-1378. doi: 10.1016/S1473-3099(19)30486-4. Epub 2019 Oct 3.

PMID:
31588039
9.

Corrigendum: Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India.

Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT.

J Gen Virol. 2019 Sep;100(9):1340. doi: 10.1099/jgv.0.001127. No abstract available.

PMID:
31481150
10.

Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Spengler JR, Welch SR, Scholte FEM, Coleman-McCray JD, Harmon JR, Nichol ST, Bergeron É, Spiropoulou CF.

Antiviral Res. 2019 Oct;170:104573. doi: 10.1016/j.antiviral.2019.104573. Epub 2019 Aug 1.

PMID:
31377243
11.

Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.

Scholte FEM, Hua BL, Spengler JR, Dzimianski JV, Coleman-McCray JD, Welch SR, McMullan LK, Nichol ST, Pegan SD, Spiropoulou CF, Bergeron É.

mBio. 2019 Jul 23;10(4). pii: e01065-19. doi: 10.1128/mBio.01065-19.

12.

Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis.

McMullan LK, Flint M, Chakrabarti A, Guerrero L, Lo MK, Porter D, Nichol ST, Spiropoulou CF, Albariño C.

Lancet Infect Dis. 2019 Sep;19(9):1023-1032. doi: 10.1016/S1473-3099(19)30291-9. Epub 2019 Jul 9.

PMID:
31300330
13.

Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Scholte FEM, Goldsmith CS, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2019 Sep 13;220(8):1281-1289. doi: 10.1093/infdis/jiz284.

PMID:
31152662
14.

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.

Lo MK, Feldmann F, Gary JM, Jordan R, Bannister R, Cronin J, Patel NR, Klena JD, Nichol ST, Cihlar T, Zaki SR, Feldmann H, Spiropoulou CF, de Wit E.

Sci Transl Med. 2019 May 29;11(494). pii: eaau9242. doi: 10.1126/scitranslmed.aau9242.

15.

Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh.

Nikolay B, Salje H, Hossain MJ, Khan AKMD, Sazzad HMS, Rahman M, Daszak P, Ströher U, Pulliam JRC, Kilpatrick AM, Nichol ST, Klena JD, Sultana S, Afroj S, Luby SP, Cauchemez S, Gurley ES.

N Engl J Med. 2019 May 9;380(19):1804-1814. doi: 10.1056/NEJMoa1805376.

16.

Comparative analysis of serologic cross-reactivity using convalescent sera from filovirus-experimentally infected fruit bats.

Schuh AJ, Amman BR, Sealy TS, Flietstra TD, Guito JC, Nichol ST, Towner JS.

Sci Rep. 2019 Apr 30;9(1):6707. doi: 10.1038/s41598-019-43156-z.

17.

Lassa Virus Targeting of Anterior Uvea and Endothelium of Cornea and Conjunctiva in Eye of Guinea Pig Model.

Gary JM, Welch SR, Ritter JM, Coleman-McCray J, Huynh T, Kainulainen MH, Bollweg BC, Parihar V, Nichol ST, Zaki SR, Spiropoulou CF, Spengler JR.

Emerg Infect Dis. 2019 May;25(5):865-874. doi: 10.3201/eid2505.181254.

18.

Using healthcare-seeking behaviour to estimate the number of Nipah outbreaks missed by hospital-based surveillance in Bangladesh.

Hegde ST, Salje H, Sazzad HMS, Hossain MJ, Rahman M, Daszak P, Klena JD, Nichol ST, Luby SP, Gurley ES.

Int J Epidemiol. 2019 Aug 1;48(4):1219-1227. doi: 10.1093/ije/dyz057.

PMID:
30977803
19.

Characterization of Novel Reoviruses Wad Medani Virus (Orbivirus) and Kundal Virus (Coltivirus) Collected from Hyalomma anatolicum Ticks in India during Surveillance for Crimean Congo Hemorrhagic Fever.

Yadav PD, Whitmer SLM, Sarkale P, Fei Fan Ng T, Goldsmith CS, Nyayanit DA, Esona MD, Shrivastava-Ranjan P, Lakra R, Pardeshi P, Majumdar TD, Francis A, Klena JD, Nichol ST, Ströher U, Mourya D.

J Virol. 2019 Jun 14;93(13). pii: e00106-19. doi: 10.1128/JVI.00106-19. Print 2019 Jul 1.

20.

Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice.

Scholte FEM, Spengler JR, Welch SR, Harmon JR, Coleman-McCray JD, Freitas BT, Kainulainen MH, Pegan SD, Nichol ST, Bergeron É, Spiropoulou CF.

Emerg Microbes Infect. 2019;8(1):575-578. doi: 10.1080/22221751.2019.1601030. No abstract available.

21.

Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response.

Spengler JR, Welch SR, Genzer SC, Coleman-McCray J, Harmon JR, Nichol ST, Spiropoulou CF.

Emerg Infect Dis. 2019 Jun;25(6):1238-1240. doi: 10.3201/eid2506.181928. Epub 2019 Jun 17.

22.

Marburg virus disease outbreak in Kween District Uganda, 2017: Epidemiological and laboratory findings.

Nyakarahuka L, Shoemaker TR, Balinandi S, Chemos G, Kwesiga B, Mulei S, Kyondo J, Tumusiime A, Kofman A, Masiira B, Whitmer S, Brown S, Cannon D, Chiang CF, Graziano J, Morales-Betoulle M, Patel K, Zufan S, Komakech I, Natseri N, Chepkwurui PM, Lubwama B, Okiria J, Kayiwa J, Nkonwa IH, Eyu P, Nakiire L, Okarikod EC, Cheptoyek L, Wangila BE, Wanje M, Tusiime P, Bulage L, Mwebesa HG, Ario AR, Makumbi I, Nakinsige A, Muruta A, Nanyunja M, Homsy J, Zhu BP, Nelson L, Kaleebu P, Rollin PE, Nichol ST, Klena JD, Lutwama JJ.

PLoS Negl Trop Dis. 2019 Mar 18;13(3):e0007257. doi: 10.1371/journal.pntd.0007257. eCollection 2019 Mar.

23.

Infection with New York Orthohantavirus and Associated Respiratory Failure and Multiple Cerebral Complications.

Fernando R, Capone D, Elrich S, Mantovani R, Quarles L 3rd, D'Amato A, Lowe N, Malhotra A, Khoo T, Zufan S, Morales-Betoulle M, Brown SM, Cannon D, Graziano JC, Klena JD, Whitmer S, Nichol ST, Strachan P, Camins BC, Marcos LA.

Emerg Infect Dis. 2019 Jun;25(6):1241-1243. doi: 10.3201/eid2506.181966. Epub 2019 Jun 17.

24.

Clinical, Histopathologic, and Immunohistochemical Characterization of Experimental Marburg Virus Infection in A Natural Reservoir Host, the Egyptian Rousette Bat (Rousettus aegyptiacus).

Jones MEB, Amman BR, Sealy TK, Uebelhoer LS, Schuh AJ, Flietstra T, Bird BH, Coleman-McCray JD, Zaki SR, Nichol ST, Towner JS.

Viruses. 2019 Mar 2;11(3). pii: E214. doi: 10.3390/v11030214.

25.

Discovery and Characterization of Bukakata orbivirus (Reoviridae:Orbivirus), a Novel Virus from a Ugandan Bat.

Fagre AC, Lee JS, Kityo RM, Bergren NA, Mossel EC, Nakayiki T, Nalikka B, Nyakarahuka L, Gilbert AT, Peterhans JK, Crabtree MB, Towner JS, Amman BR, Sealy TK, Schuh AJ, Nichol ST, Lutwama JJ, Miller BR, Kading RC.

Viruses. 2019 Mar 2;11(3). pii: E209. doi: 10.3390/v11030209.

26.

First Laboratory-Confirmed Outbreak of Human and Animal Rift Valley Fever Virus in Uganda in 48 Years.

Shoemaker TR, Nyakarahuka L, Balinandi S, Ojwang J, Tumusiime A, Mulei S, Kyondo J, Lubwama B, Sekamatte M, Namutebi A, Tusiime P, Monje F, Mayanja M, Ssendagire S, Dahlke M, Kyazze S, Wetaka M, Makumbi I, Borchert J, Zufan S, Patel K, Whitmer S, Brown S, Davis WG, Klena JD, Nichol ST, Rollin PE, Lutwama J.

Am J Trop Med Hyg. 2019 Mar;100(3):659-671. doi: 10.4269/ajtmh.18-0732.

27.

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF.

Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.

28.

A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus.

Flint M, Chatterjee P, Lin DL, McMullan LK, Shrivastava-Ranjan P, Bergeron É, Lo MK, Welch SR, Nichol ST, Tai AW, Spiropoulou CF.

Nat Commun. 2019 Jan 17;10(1):285. doi: 10.1038/s41467-018-08135-4.

29.

Adaptive Immune Responses in Humans During Nipah Virus Acute and Convalescent Phases of Infection.

Arunkumar G, Devadiga S, McElroy AK, Prabhu S, Sheik S, Abdulmajeed J, Robin S, Sushama A, Jayaram A, Nittur S, Shakir M, Kumar KGS, Radhakrishnan C, Sakeena K, Vasudevan J, Reena KJ, Sarita RL, Klena JD, Spiropoulou CF, Laserson KF, Nichol ST.

Clin Infect Dis. 2019 Oct 30;69(10):1752-1756. doi: 10.1093/cid/ciz010.

PMID:
30615097
30.

Antibody-Mediated Virus Neutralization Is Not a Universal Mechanism of Marburg, Ebola, or Sosuga Virus Clearance in Egyptian Rousette Bats.

Schuh AJ, Amman BR, Sealy TK, Kainulainen MH, Chakrabarti AK, Guerrero LW, Nichol ST, Albarino CG, Towner JS.

J Infect Dis. 2019 May 5;219(11):1716-1721. doi: 10.1093/infdis/jiy733.

31.

Complete Genome Sequences of Monongahela Hantavirus from Pennsylvania, USA.

Albariño CG, Wiggleton Guerrero L, Chakrabarti AK, Rollin PE, Nichol ST.

Microbiol Resour Announc. 2018 Sep 20;7(11). pii: e00928-18. doi: 10.1128/MRA.00928-18. eCollection 2018 Sep.

32.

Care of Ebola Survivors and Factors Associated With Clinical Sequelae-Monrovia, Liberia.

de St Maurice A, Ervin E, Orone R, Choi M, Dokubo EK, Rollin PE, Nichol ST, Williams D, Brown J, Sacra R, Fankhauser J, Knust B.

Open Forum Infect Dis. 2018 Sep 21;5(10):ofy239. doi: 10.1093/ofid/ofy239. eCollection 2018 Oct.

33.

Notes from the Field: Contact Tracing Investigation after First Case of Andes Virus in the United States - Delaware, February 2018.

Kofman A, Eggers P, Kjemtrup A, Hall R, Brown SM, Morales-Betoulle M, Graziano J, Zufan SE, Whitmer SLM, Cannon DL, Chiang CF, Choi MJ, Rollin PE, Cetron MS, Yaglom HD, Duwell M, Kuhar DT, Kretschmer M, Knust B, Klena JD, Alvarado-Ramy F, Shoemaker T, Towner JS, Nichol ST.

MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1162-1163. doi: 10.15585/mmwr.mm6741a7. No abstract available.

34.

Notes from the Field: Exported Case of Sin Nombre Hantavirus Pulmonary Syndrome - Israel, 2017.

Kofman A, Rahav G, Yazzie D, Shorty H, Yaglom HD, Peterson D, Peek-Bullock M, Choi MJ, Wieder-Finesod A, Klena JD, Venkat H, Chiang CF, Knust B, Gaither M, Maurer M, Hoeschele DR, Nichol ST.

MMWR Morb Mortal Wkly Rep. 2018 Oct 12;67(40):1129. doi: 10.15585/mmwr.mm6740a5. No abstract available. Erratum in: MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1197.

35.

CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.

Harmon JR, Spengler JR, Coleman-McCray JD, Nichol ST, Spiropoulou CF, McElroy AK.

J Virol. 2018 Nov 27;92(24). pii: e01270-18. doi: 10.1128/JVI.01270-18. Print 2018 Dec 15.

36.

Characterization of Unknown Orthobunya-Like Viruses from India.

Whitmer SLM, Yadav PD, Sarkale P, Chaubal GY, Francis A, Klena J, Nichol ST, Ströher U, Mourya DT.

Viruses. 2018 Aug 24;10(9). pii: E451. doi: 10.3390/v10090451.

37.

Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses.

Albariño CG, Wiggleton Guerrero L, Chakrabarti AK, Nichol ST.

PLoS One. 2018 Aug 2;13(8):e0201827. doi: 10.1371/journal.pone.0201827. eCollection 2018.

38.

The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model.

Welch SR, Scholte FEM, Albariño CG, Kainulainen MH, Coleman-McCray JD, Guerrero LW, Chakrabarti AK, Klena JD, Nichol ST, Spengler JR, Spiropoulou CF.

Front Cell Infect Microbiol. 2018 Jul 11;8:240. doi: 10.3389/fcimb.2018.00240. eCollection 2018.

39.

Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice.

Spengler JR, McElroy AK, Harmon JR, Coleman-McCray JD, Welch SR, Keck JG, Nichol ST, Spiropoulou CF.

PLoS One. 2018 Jul 20;13(7):e0201104. doi: 10.1371/journal.pone.0201104. eCollection 2018.

40.

Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection.

McElroy AK, Harmon JR, Flietstra T, Nichol ST, Spiropoulou CF.

J Infect Dis. 2018 Oct 20;218(11):1847-1851. doi: 10.1093/infdis/jiy393.

41.

Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India.

Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT.

J Gen Virol. 2018 Aug;99(8):991-1000. doi: 10.1099/jgv.0.001102. Epub 2018 Jun 25.

PMID:
29939123
42.

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Klena JD, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2018 May 25;217(12):1957-1966. doi: 10.1093/infdis/jiy123.

43.

Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.

Smith DR, Johnston SC, Piper A, Botto M, Donnelly G, Shamblin J, Albariño CG, Hensley LE, Schmaljohn C, Nichol ST, Bird BH.

PLoS Negl Trop Dis. 2018 May 9;12(5):e0006474. doi: 10.1371/journal.pntd.0006474. eCollection 2018 May.

44.

Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations.

de St Maurice A, Harmon J, Nyakarahuka L, Balinandi S, Tumusiime A, Kyondo J, Mulei S, Namutebi A, Knust B, Shoemaker T, Nichol ST, McElroy AK, Spiropoulou CF.

PLoS Negl Trop Dis. 2018 May 4;12(5):e0006460. doi: 10.1371/journal.pntd.0006460. eCollection 2018 May.

45.

Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in Southwestern Uganda, 2016.

Nyakarahuka L, de St Maurice A, Purpura L, Ervin E, Balinandi S, Tumusiime A, Kyondo J, Mulei S, Tusiime P, Lutwama J, Klena JD, Brown S, Knust B, Rollin PE, Nichol ST, Shoemaker TR.

PLoS Negl Trop Dis. 2018 May 3;12(5):e0006412. doi: 10.1371/journal.pntd.0006412. eCollection 2018 May.

46.

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.

Shrivastava-Ranjan P, Flint M, Bergeron É, McElroy AK, Chatterjee P, Albariño CG, Nichol ST, Spiropoulou CF.

mBio. 2018 May 1;9(3). pii: e00660-18. doi: 10.1128/mBio.00660-18.

47.

Equine Encephalosis Virus in India, 2008.

Yadav PD, Albariño CG, Nyayanit DA, Guerrero L, Jenks MH, Sarkale P, Nichol ST, Mourya DT.

Emerg Infect Dis. 2018 May;24(5):898-901. doi: 10.3201/eid2405.171844.

48.

Susceptibility of paramyxoviruses and filoviruses to inhibition by 2'-monofluoro- and 2'-difluoro-4'-azidocytidine analogs.

Lo MK, Jordan PC, Stevens S, Tam Y, Deval J, Nichol ST, Spiropoulou CF.

Antiviral Res. 2018 May;153:101-113. doi: 10.1016/j.antiviral.2018.03.009. Epub 2018 Mar 27.

49.

Impact of enhanced viral haemorrhagic fever surveillance on outbreak detection and response in Uganda.

Shoemaker TR, Balinandi S, Tumusiime A, Nyakarahuka L, Lutwama J, Mbidde E, Kofman A, Klena JD, Ströher U, Rollin PE, Nichol ST.

Lancet Infect Dis. 2018 Apr;18(4):373-375. doi: 10.1016/S1473-3099(18)30164-6. Epub 2018 Mar 21. No abstract available.

50.

Complete Genome Sequences of a Hantavirus Isolate from New York.

McMullan LK, Albariño CG, Ksiazek TG, Nichol ST, Spiropoulou CF.

Genome Announc. 2018 Mar 22;6(12). pii: e00188-18. doi: 10.1128/genomeA.00188-18.

Supplemental Content

Loading ...
Support Center